SCHEMBL8167995

SCHEMBL8167995

C=CC(Cl)OC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16411794 0.75
SCHEMBL706687 0.75
SCHEMBL2260752 0.69
SCHEMBL83336 0.67
SCHEMBL28683727 0.67
SCHEMBL175055 0.67
SCHEMBL2168484 0.67
SCHEMBL1148829 0.67
SCHEMBL408599 0.67
SCHEMBL27860974 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230000812-A1 IBUPROFEN ESTER PRODRUG, PHARMACEUTICAL COMPOSITION, PREPARATION METHOD AND APPLICATION NANJING HERON PHARMACEUTICAL SCIENCE AND TECHNOLOGY CO., LTD. (CN) 2023-01-05 US claimed
CN-114728883-A Ibuprofen ester prodrug, pharmaceutical composition, preparation method and application 南京海融医药科技股份有限公司 2022-07-08 CN claimed
EP-3984989-A1 IBUPROFEN ESTER PRODRUG, PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD AND USE Nanjing Heron Pharmaceutical Science and Technology Co., Ltd. (CN) 2022-04-20 EP claimed
WO-1999011202-A1 BIOMIMETIC CALCIUM PHOSPHATE IMPLANT COATINGS AND METHODS FOR MAKING THE SAME ICET, INC. (US) 1999-03-11 WO claimed
US-20230000812-A1 IBUPROFEN ESTER PRODRUG, PHARMACEUTICAL COMPOSITION, PREPARATION METHOD AND APPLICATION NANJING HERON PHARMACEUTICAL SCIENCE AND TECHNOLOGY CO., LTD. (CN) 2023-01-05 US disclosed
CN-114746394-A Aryl propionic acid derivative, pharmaceutical composition, preparation method and application thereof 南京海融医药科技股份有限公司 2022-07-12 CN disclosed
CN-114728883-A Ibuprofen ester prodrug, pharmaceutical composition, preparation method and application 南京海融医药科技股份有限公司 2022-07-08 CN disclosed
EP-4001258-A1 ARYL PROPIONIC ACID DERIVATIVE, PHARMACEUTICAL COMPOSITION, AND METHOD FOR PREPARATION THEREOF AND APPLICATION THEREOF Nanjing Heron Pharmaceutical Science and Technology Co., Ltd. (CN) 2022-05-25 EP disclosed
US-20220153777-A1 METHOD FOR PRODUCING PEPTIDE COMPOUND NISSAN CHEMICAL CORPORATION (JP) 2022-05-19 US disclosed
EP-3984989-A1 IBUPROFEN ESTER PRODRUG, PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD AND USE Nanjing Heron Pharmaceutical Science and Technology Co., Ltd. (CN) 2022-04-20 EP disclosed
EP-3939959-A1 METHOD FOR PRODUCING PEPTIDE COMPOUND Nissan Chemical Corporation (JP) 2022-01-19 EP disclosed
CN-110035993-A SUBSTITUTED PYRROLIDINES AS CFTR MODULATORS 艾伯维公司 2019-07-19 CN disclosed
CN-107847607-A Aptamer conjugate of paclitaxel or derivative thereof, and preparation method and application thereof 北京和理咨询有限公司 2018-03-27 CN disclosed
CN-102271504-A PROCESS AND INTERMEDIATES FOR THE PREPARATION OF N-ACYLATED-4-ARYL BETA-AMINO ACID DERIVATIVES 2011-12-07 CN disclosed
US-6129928-A METAL IMPLANT SURFACE IS OXIDIZED, CHEMISORBS A NUCLEATING AGENT; THEN THE IMPLANT IS EXPOSED TO A CALCIUM PHOSPHATE FORMING SOLUTION AND NUCLEATING AGENT AT A FIXED PH; CAN BE REINFORCED WITH HYDROGEL COUPLED TO GROWTH FACTOR ICET, INC. (US) 2000-10-10 US disclosed
US-5563230-A POLYETHERSILOXANES NATIONAL SCIENCE COUNCIL (TW) 1996-10-08 US disclosed
US-5495037-A MESOGENIC SIDE CHAINS NATIONAL SCIENCE COUNCIL (TW) 1996-02-27 US disclosed
EP-0551993-A1 Pyrrolidine derivatives and process for preparing the same SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1993-07-21 EP disclosed
US-4528315-A Process for the preparation of polymer dispersions and their application WACKER-CHEMIE GMBH (DE) 1985-07-09 US disclosed